Biodegradable magnesium implants
Biodegradable magnesium implants (also referred to as bioabsorbable magnesium implants, resorbable magnesium implants, or degradable magnesium implants) are temporary surgical implants fabricated from magnesium and its alloys that…
≈ 3 min read
Biodegradable magnesium implants. encyclopegia.org, snapshot enwiki-001372910995. /a/biodegradable-magnesium-implants
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Biodegradable magnesium implants (also referred to as bioabsorbable magnesium implants, resorbable magnesium implants, or degradable magnesium implants) are temporary surgical implants fabricated from magnesium and its alloys that gradually dissolve within the body's physiological environment during and after bone healing. Unlike conventional permanent implants made from titanium or stainless steel, a bioabsorbable device is designed to degrade once the bone has healed, eliminating the need for a secondary surgical removal procedure.
Magnesium is the fourth most abundant cation in the human body and an essential component of bone mineral, contributing to its inherent biocompatibility. Its elastic modulus (41–45 GPa) is considerably closer to that of cortical bone (10–30 GPa) than conventional permanent metallic biomaterials such as titanium alloys (~110 GPa) or stainless steel (~200 GPa), reducing the stress shielding effect that can inhibit bone remodelling and lead to bone resorption.
Beyond passive compatibility, magnesium ions released during degradation have been shown to actively promote osteogenesis, stimulate angiogenesis, and modulate immune responses in the bone microenvironment. The principal clinical forms include screws, pins, plates, and intramedullary nails used in fracture fixation, as well as bioresorbable coronary scaffolds.
The first regulatory-approved resorbable metallic orthopaedic implant—the MAGNEZIX® compression screw (Syntellix AG, Germany)—received CE marking in 2013. As of 2026, multiple companies across Europe, Asia, and North America hold approved or breakthrough-designated products, targeting markets in orthopaedic trauma and spinal surgery valued in excess of USD 9 billion.
Despite growing clinical adoption, challenges related to corrosion rate control, stress corrosion cracking (SCC), hydrogen gas evolution, and regulatory standardisation continue to restrict broader deployment. An active area of research involves developing quantitative design parameters—such as SCC stress thresholds—to support safe implant design beyond comparative susceptibility ranking.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372910995 under CC BY-SA 4.0; modifications have been made.